Treatment of Recurrent Epithelial Ovarian Cancer
نویسندگان
چکیده
منابع مشابه
Treatment of recurrent epithelial ovarian cancer
Epidemiologic analysis reveals that the mortality rate from ovarian cancer is continuously decreasing due to the improvement of surgery and chemotherapy. However, the prognosis of ovarian cancer patients is still unsatisfactory overall considering that only 30% of patients are alive after five years. In fact, although surgery and first-line systemic chemotherapy induces complete and partial res...
متن کاملTCRM-4317-Treatment of recurrent epithelial ovarian cancer
Correspondence: Sandro Pignata Divisione di Oncologia Medica, Dipartimento Uro-Ginecologico, istituto Nazionale Tumori, via M. Semmola, 80131 – Napoli – italy Tel +39 81 590 3637 Fax +39 81 590 3861 email [email protected] Abstract: Epidemiologic analysis reveals that the mortality rate from ovarian cancer is continuously decreasing due to the improvement of surgery and chemot...
متن کاملRecurrent epithelial ovarian cancer: an update on treatment.
An estimated 85% of patients with epithelial ovarian cancer who achieve a full remission following first-line therapy will develop recurrent disease. Although each subsequent line of therapy is characterized by shorter disease-free intervals, median survival for these patients ranges from 12 months to 24 months. Emerging therapies in the management of ovarian cancer have resulted in a shift in ...
متن کاملTreatment of recurrent ovarian cancer.
Recurrent ovarian cancer is a common clinical problem and the management of each patient must be individualized. Diagnosis is usually based on a progressively rising CA-125 titre, and a CT scan of the pelvis and abdomen, together with a chest X-ray should be performed in this situation. Although there is no study to support immediate treatment in the asymptomatic patient, our approach is to com...
متن کاملAdvances in treatment of epithelial ovarian cancer.
Since most cases of epithelial ovarian cancer are advanced at diagnosis, this disease is one of the most lethal malignancies of the female genital tract. In recent years, aggressive cytoreductive surgery and chemotherapy have been employed in an attempt to improve the survival rate in patients with epithelial ovarian cancer. Introduction of platinum anticancer drugs increased survival rate, and...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Geburtshilfe und Frauenheilkunde
سال: 2020
ISSN: 0016-5751,1438-8804
DOI: 10.1055/a-1128-0280